Transcutaneous iontophoresis of methadone provokes local flushing and thermal hyperalgesia

Inflammation Research

Volumn 52, Issue 9, 2003, Pages 366-371

  Drummond, P D ^a   De Silva Rossdeutscher, E ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

Iontophoresis; Methadone; Neurogenic inflammation; Peripheral opioid analgesia; Thermal hyperalgesia

Indexed keywords

METHADONE; MU OPIATE RECEPTOR; NALOXONE; SODIUM CHLORIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG HALF LIFE; FEMALE; FLUSHING; HEAT ACCLIMATIZATION; HEAT SENSITIVITY; HUMAN; HYPERALGESIA; INHIBITION KINETICS; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; PAIN THRESHOLD; SIDE EFFECT; SKIN BLOOD FLOW; URTICARIA; VASODILATATION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; FEMALE; FLUSHING; HEAT; HUMANS; HYPERALGESIA; IONTOPHORESIS; MALE; METHADONE; MIDDLE AGED; NALOXONE; PAIN; PAIN MEASUREMENT; REGIONAL BLOOD FLOW; SKIN;

EID: 0141519365     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1188-2     Document Type: Article

References (29)

1. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995; 332: 1685-90.
2. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293: 311-5.
3. Andreev N, Urban L, Dray A. Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation. Neuroscience 1994; 58: 793-8.
4. Williamson DJ, Shepheard SL, Cook DA, Hargreaves RJ, Hill RG, Cumberbatch MJ. Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats. Br J Pharmacol 2001; 133: 807-14.
5. Taylor BK, Peterson MA, Roderick RE, Tare J, Green PG, Levine JO, et al. Opioid inhibition of formalin-induced changes in plasma extravasation and local blood flow in rats. Pain 2000; 84: 263-70.
6. Barke KE, Hough LB. Opiates, mast cells and histamine release. Life Sci 1993; 53: 1391-9.
7. Casale TB, Bowman S, Kaliner M. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 1984; 73: 775-81.
8. Hermens JM, Ebertz JM, Hanifin JM, Hirshman CA. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone. Anesthesiology 1985; 62: 124-9.
9. Saucedo R, Erill S. Morphine-induced skin wheals: a possible model for the study of histamine release. Clin Pharmacol Ther 1985; 38: 365-70.
10. Levy JH, Brister NW, Shearin A, Ziegler J, Hug CC Jr. Adelson DM, et al. Wheal and flare responses to opioids in humans. Anesthesiology 1989; 70: 756-60.
11. Ebertz JM, Hermens JM, McMillan JC, Uno H, Hirshman C, Hanifin JM. Functional differences between human cutaneous mast cells and basophils: a comparison of morphine-induced histamine release. Agents Actions 1986; 18: 455-62.
12. Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM, Sullivan TJ. Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol 1987; 79: 646-53.
13. Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy 1997; 27: 284-95.
14. Thompson WL, Walton RP. Elevation of plasma histamine levels in the dog following administration of muscle relaxants, opiates and macromolecular polymers. J Pharmacol Exp Ther 1964; 143: 131-6.
15. Zelis R, Mansour EJ, Capone RJ, Mason DT. The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects. J Clin Invest 1974; 54: 1247-58.
16. Zelis R, Flaim SF, Eisele JH. Effects of morphine on reflex arteriolar constriction induced in man by hypercapnia. Clin Pharmacol Ther 1977; 22: 172-8.
17. Flaim SF, Zelis R, Eisele JH. Differential effects of morphine on forearm blood flow: attenuation of sympathetic control of the cutaneous circulation. Clin Pharmacol Ther 1978; 23: 542-6.
18. Cohen RA, Coffman JD. Naloxone reversal of morphine-induced peripheral vasodilatation. Clin Pharmacol Ther 1980; 28: 541-4.
19. Cohen RA, Coffman JD. Effect of morphine on limb capacitance and resistance vessels. Clin Sci (Lond) 1981; 60: 5-9.
20. Bruera E, Fainsinger R, Moore M, Thibault R, Spoldi E, Ventafridda V. Local toxicity with subcutaneous methadone. Experience of two centers. Pain 1991; 45: 141-3.
21. Di Bello MG, Masini E, Ioannides C, Fomusi Ndisang J, Raspanti S, Bani Sacchi T, et al. Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm Res 1998; 47: 122-30.
22. Stefano GB, Goumon Y, Bilfinger TV, Welters ID, Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 2000; 60: 513-30.
23. Kellogg D, Lui Y, Kosiba I, O'Donnell D. Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 1999; 86: 1185-90.
24. Archer AG, Benroubi M, Pyke DA, Wiles PG. Naloxone increases blood flow in the human hand. J Physiol 1985; 363: 315-21.
25. Ko M, Butelman E, Woods J. The role of peripheral Mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys. J Pharmacol Exp Ther 1998; 286: 150-6.
26. Holthusen H, Arndt JO. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett 1994; 165: 71-4.
27. Holthusen H, Arndt JO. Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. J Physiol 1995; 487: 253-8.
28. Sato K, Timm D, Sato F, Templeton E, Meletiou D, Toyomoto T, et al. Generation and transit pathway of H+ is critical for inhibition of palmar sweating by iontophoresis in water. J Applied Physiol 1993; 75: 2258-64.
29. Nozaki-Taguchi N, Yaksh T. Characterization of the antihyperalgesic action of a novel peripheral Mu-opioid receptor agonist loperamide. Anesthesiol 1999; 90: 225-34.